Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > CORPORATE PRESENTATION 2024-03-01

<< Previous

Bullboard Posts

Next >>

Comment by O12009on Mar 12, 2024 2:47pm

224 Views

Post# 35928963

RE:RE:RE:RE:RE:RE:CORPORATE PRESENTATION 2024-03-01

If you look at the time lines, it says commercialization to begin in 2024. I'm thinking that they are waiting for BTD so they will get paid to treat the rest of the patients. A penny saved is a penny earned.
They have been able to get this treatment this far on the dime. No reason to change.

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property